SEC Form 4 · accession 0000903423-17-000030
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather Preston
Director
Period of report
Jan 23, 2017
Accepted (ET)
Jan 25, 2017 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.54 | Jan 23, 2017 | A | 4,500 | A | — | Jan 22, 2027 | Common Stock | 4,500 | 4,500 | D |
Explanation of responses
- F1The option will vest and become exercisable in equal annual installments on each of the first three anniversaries of the date of the grant (provided that, in any case, the option will fully vest on the day prior to the annual meeting for the third fiscal year following the date of the grant).
Remarks
(2) Michael LaGatta is signing on behalf of Ms. Preston pursuant to the authorization and designation letter dated October 6, 2016, which was previously filed with the Securities and Exchange Commission.